Endocrinology

Top Story

Enrollment begins for predictive low glucose trial

August 19, 2017

Tandem Diabetes Care has announced the enrollment of the first participant in an at-home trial assessing predictive low glucose suspend technology, according to a press release.

The trial will assess the safety and efficacy of Tandem’s t:slim X2 insulin pump with predictive low glucose suspend, which suspends insulin delivery when glucose gets to low and resumes delivery when glucose rises. The trial will also use Dexcom’s G5 mobile continuous glucose monitor as part of the delivery system.

In the Journals Plus

RYGB-induced weight loss alters postprandial FGF21 metabolism

August 18, 2017
Postprandial fibroblast growth factor 21 metabolism is uniquely affected by Roux-en-Y gastric bypass-induced weight loss, according to findings published in The Journal
In the Journals Plus

Hyperglycemia, insulin resistance tied to low trabecular bone score in older men

August 18, 2017
Japanese men with hyperglycemia and higher levels of insulin resistance are more likely to have a lower trabecular bone score than men who are not insulin resistant…

Biocept, UT Southwestern to study liquid biopsy platform in ALK-positive non-small cell lung cancer

August 18, 2017
Biocept Inc. and University of Texas Southwestern Medical Center entered a clinical study agreement to evaluate the clinical utility of Biocept’s Target Selector…
In the Journals Plus

IV to subcutaneous insulin transition rate low in ICU

August 18, 2017
Rates of transition from IV insulin infusion to subcutaneous insulin were low in an ICU setting, according to researchers from Cleveland Clinic. Their findings highlight
More Headlines »
CME

Diabetic Eye 2015: New Concepts in Screening, Managing, and Referral

This activity is supported by an educational grant from Allergan, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Video
Meeting News

VIDEO: AADE addressing place of diabetes educators in changing health care landscape

August 7, 2017
More »
Resource Centers
CME

Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement